Abstract
Transsphenoidal pituitary microsurgery is considered as the best treatment of Cushing’s disease. However, some recent studies reported disappointing results, leading their authors to suggest the possibility of returning to a first line adrenalectomy treatment. The aim of this study was to evaluate long-term results of transsphenoidal surgery in Cushing’s disease, with special interest in factors that could affect the surgical outcome on the one hand and particular attention to surgical endocrine effects on the other. Fifty consecutive patients (34 females, 16 males, mean age 29.64±1.52 yr) were studied. The median post-operative follow-up was 71.5 months (range 25–219). Clinical, biological, surgical and pathological data between the success and failure groups were compared. Criteria of cure were: normal urinary free Cortisol excretion, circadian Cortisol rhythm and low dose dexamethasone test. Recovery of corticotroph and somatotroph functions were followed using the insulin test. Particular attention is given to clinical evolution in evaluating other pituitary functions. T4 or FT4, prolactin, E2 in women, testosterone in men, were measured. TRH and LHRH tests were not systematically performed. Only two parameters differed significantly between the cured and failure groups: the size of the adenomas was smaller and the pathological confirmation of the adenoma more frequent in the cured group. One patient had permanent corticotropic failure while two other had impaired response to hypoglycemia with normal cortisol basal levels. No acquired hypothyroidism nor hypogonadism were observed except in a patient who underwent two operations and radiotherapy. Recovery of GH function was slow. Definitive short stature was observed in all the patients whose disease began before the age of 16. Two patients had permanent diabetes insipidus. In conclusion, the most favorable prognosis in transsphenoidal surgery for Cushing’s disease is observed in case of microadenoma confirmed by pathological examination. With this treatment, we obtained satisfactory results in Cushing’s disease with minimal complications and no necessity of lifelong endocrine substitutive therapy.
Similar content being viewed by others
References
Melby J.C. Therapy of Cushing’s aisease: A consensus for pituitary microsurgery. Ann. Intern. Med. 109: 445, 1988.
Atkinson A.B. The treatment of Cushing’s syndrome. Clin. Endocrinol. (Oxf.) 6: 507, 1991.
Burke C.W., Adams C.B.T., Esiri M.M., Morris C., Bevall J.S. Transsphenoidal surgery for Cushing’s disease: Does what is removed determine the endocrine outcome? Clin. Endocrinol. (Oxf.) 33: 525, 1990.
McCance D.R., Gordon D.S., Fannin T.F., Hadden D.R., Kennedy L., Sheridan B., Atkinson A.B. Assessment of endocrine function after transsphenoidal surgery for Cushing’s disease. Clin. Endocrinol. (Oxf.) 38: 79, 1993.
Lindholm J. Endocrine function in patients with Cushing’s disease before and after treatment. Clin. Endocrinol. (Oxf.) 36: 151, 1992.
Trainer P.J., Lawrie H.S., Verhelst J., Howlett T.A., Lowe D.G., Grossman A.B., Savage M.O., Afshar F., Besser G.M. Transsphenoidal resection in Cushing’s disease: Undectectable serum cortisol as the definition of successful treatment. Clin. Endocrinol. (Oxf.) 38: 73, 1993.
Tagliaferri M., Berselli M.E., Loli P. Transsphenoidal micro-surgery for Cushing’s diseise. Acta Endocrirnol. (Copenh.) 113: 5, 1986.
Mampalam T.J., Tyrrell J.B., Wilson C.B. Transsphenoidal micro-surgery for Cushing disease: A report of 216 cases. Ann. Intern. Med. 109: 487, 1988.
Lamberts S.W.J., Klijn J.G.M., DeJong F.H. The definition of true recurrence of pituitary dependent Cushing’s syndrome after transsphenoidal operation. Clin. Endocrinol. (Oxf.) 26: 707, 1987.
Jeffcoate W.J., Dauncey S., Selby C. Restoration for dexamethasone suppression by incomplete adenomectomy in Cushing’s disease. Clin. Endocrinol. (Oxf.) 23: 193, 1985.
Vignati F., Berselli M.E., Loli P. Early postoperative evaluation in patients-with Cushing’s disease: Usefulness of ovine cortico-tropin-releasing hormone test in the prediction of recurrence of disease. Eur. J. Endocrinol. 130: 235, 1994.
Chandler W.F., Schteingart D.F., Lloyd R.V., McKeever P.E., Ibarra-Perez G. Surgical treatment of Cushing’s disease. J. Neurosurg. 66: 204, 1987.
Guilhaume B., Bertagna X., Thomsen M., Bricaire C., Vila-Porcile E., Olivier L., Racadot J., Derome P., Laudat M.H., Girard F., Bricaire H., Luton J.E. Transsphenoidal pituitary surgery for the treatment of Cushing’s disease: Results in 64 patients and long-term follow-up studies. J. Clin. Endocrinol. Metab. 66: 1056, 1988.
Salassa R.M., Laws E.R., Carpenter P.C., Northcutt R.C. Transsphenoidal removal of pituitary microadenomas in Cushing’s disease. Mayo Clinic Proc. 53: 24, 1986.
Comtois R., Beauregard H., Hardy J., Robert F., Somma M. High prolactin levels in patients with Cushing’s disease without pathological evidence of pituitary adenoma. Clin. Endocrinol. (Oxf.) 38: 601, 1993.
Semple C.G., Thomson J.A., Teasdale G.M. Trassphenoidal micro-surgery for Cushing’s disease. Clin. Endocrinol. (Oxf.) 21: 621, 1984.
Findling J.W., Tyrell J.B. Occult ectopic secretion of corticotropin. Arch. Intern. Med. 146: 929, 1986.
Tindall G.T., Herring C.J., Clark R.V., Adams A.D., Watts N.B. Cushing’s disease: results of transsphenoidal microsurgery with emphasis on surgical failures. J. Neurosurg. 72: 363, 1990.
Gicquel C., LeBouc Y., Luton J.P., Girard F., Bertagna X. Monoclonality of corticotroph macroadenomas in Cushing’s disease. J. Clin. Endocrinol. Metab. 75: 472, 1992.
Lamberts S.W.J., Zuiderwijk J., Uitterlinden P., Blijd J.J., Bruining H.A., DeJong F.H. Characterization of adrenal autonomy in Cushing’s syndrome: A comparison between in vivo and in vitro responsiveness of the adrenal gland. J. Clin. Endocrinol. Metab. 70: 192, 1990.
Hocher B., Bähr V., Dorfmüller S., Oelkers W. Hypercortisolism with non-pigmented micronodular adrenal hyperplasia: from pituitary-dependent to adrenal-dependent Cushing’s syndrome. Acta Endocrinol. (Copenh.) 128: 120, 1993.
Thomas J.P., Richards S.H. Long-term results of radical hypophysectomy for Cushing’s disease. Clin. Endocrinol. (Oxf.) 19: 629, 1983.
Fahlbusch R., Buchfelder M., Müller O.A. Transsphenoidal surgery for Cushing’s disease. J. R. Soc. Med. 79: 262, 1986.
Fitzgerald P.A., Aron D.C., Findling J.W., Brooks R.M., Wilson C.B., Forsham P.H., Tyrrel J.B. Cushing’s disease: Transient secondary adrenal insufficiency after selective removal of pituitary microadenoma; evidence for a pituitary origin. J. Clin. Endocrinol. Metab. 54: 413, 1982.
Avgerinos P.C., Chrousos G.P., Nieman L.K., Oldfield E.H., Loriaux D.L., Cutler G.B. The corticotropin-releasing hormone test in the postoperative evaluation of patients with Cushing’s syndrome. J. Clin. Endocrinol. Metab. 65: 906, 1987.
Schrell U., Fahlbusch R., Buchfelder M., Riedl S., Stalla G.K., Müller O.A. Corticotroph hormone stimulation test before and after transsphenoidal selective microadenomectomy in 30 patients with Cushing’s disease. J. Clin. Endocrinol. Metab. 64: 1150, 1987.
Nakane T., Kuwayama A., Watanabe M., Takahashi T., Kato T., Ichihara K., Kageyama N. Long-term results of transsphenoidal adenomectomy in patients with Cushing’s disease. Neurosurgery 21: 218, 1987.
Suda T., Demura H., Demura R., Jibiki K., Tozawa F., Shizume K. Anterior pituitary hormones in plasma and pituitaries from patients with Cushing’s disease. J. Clin. Endocrinol. Metab. 51: 1048, 1980.
Gomez M.T., Magiakou M.A., Mastorakos G., Chrousos G.P. The pituitary corticotroph is not the rate limiting step in the postoperative recovery of the hypothalamic-pituitary adrenal axis in patients with Cushing’s syndrome. J. Clin. Endocrinol. Metab. 77: 173, 1993.
Bakiri F., Djemli K., Maoui R., Chitour F., Benmiloud M. Evolution post-opératoire à long terme des tumeurs benignes de la corticosurrenale. XIII Congrès Français d’Endocrinologie, 1995 (Abstract).
Kuwayama A., Kageyama N., Nakane T., Watanabe M., Kanie N. Anterior pituitary function after transphenoidal selective adenomectomy in patients with Cushing’s disease. J. Clin. Endocrinol. Metab. 53: 165, 1981.
Styne D.M., Grumbach M.M., Kaplan S.L., Wilson C.B., Conte E.A. Treatment of Cushing’s disease in childhood and adolescence by transsphenoidal microadenomectomy. N. Engl. J. Med. 310: 889, 1984.
Magiakou M.A., Mastorakos G., Gomez M.T., Rose S.R., Chrousos G.P. Suppressed spontaneous and stimulated growth hormone secretion in patients with Cushing’s disease before and after surgical cure. J. Clin. Endocrinol. Metab. 78: 131, 1994.
McCance D.R., Russell C.F.J., Kennedy T.L., Hadden D.R., Kennedy L., Atkinson A.B. Bilateral adrenalectomy: Low mortality and morbidity in Cushing’s disease. Clin. Endocrinol. (Oxf.) 39: 315, 1993.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Bakiri, F., Tatai, S., Aouali, R. et al. Treatment of Cushing’s disease by transsphenoidal, pituitary microsurgery: prognosis factors and long-term follow-up. J Endocrinol Invest 19, 572–580 (1996). https://doi.org/10.1007/BF03349020
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03349020